Drug Profile
Naloxone - Altovida
Alternative Names: ALT-022; MVP-005; MVP-022Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Mitovie Pharma
- Developer Altovida; Mitovie Pharma
- Class Antidotes; Behavioural disorder therapies; Benzofurans; Drug withdrawal therapies; Isoquinolines; Ketones; Laxatives; Morphinans; Small molecules
- Mechanism of Action Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Opioid-related disorders
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for preclinical development in Opioid-abuse in United Kingdom (IM, Injection)
- 18 Aug 2015 No development reported - Preclinical for Opioid abuse in United Kingdom (Intranasal)